ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 327 filers reported holding ROYALTY PHARMA PLC in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,289 | -57.2% | 84 | -40.8% | 0.00% | – |
| Q2 2023 | $5,342 | -78.6% | 142 | -74.6% | 0.00% | -100.0% |
| Q1 2023 | $24,920 | +166033.3% | 560 | +69.2% | 0.00% | – |
| Q4 2022 | $15 | -99.9% | 331 | +5.4% | 0.00% | – |
| Q3 2022 | $14,000 | 0.0% | 314 | +0.6% | 0.00% | – |
| Q2 2022 | $14,000 | -51.7% | 312 | -52.4% | 0.00% | – |
| Q1 2022 | $29,000 | +2800.0% | 655 | +6450.0% | 0.00% | – |
| Q4 2021 | $1,000 | – | 10 | – | 0.00% | – |
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q4 2020 | $2,000 | -94.4% | 38 | -95.5% | 0.00% | -100.0% |
| Q3 2020 | $36,000 | +89.5% | 850 | +112.5% | 0.00% | 0.0% |
| Q2 2020 | $19,000 | – | 400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |